Sunday, February 18, 2018

Social Change Blog Topic

In the United States, the role of primary care physicians in behavioral medicine has significantly changed over the past several decades (Olfson et al, 2002; Kroenke et al, 2010; Coyne et al, 2002). Studies suggest that primary care physicians now prescribe more than 80% of antidepressants and other psychotropic medications for the population presenting with depressive disorders (Barkil-Oteo, 2013; Kroenke et al 2010). This is a dramatic increase since the late 1980’s when only about 35% of psychotropic medications were being prescribed by primary care physicians (Olfson et al, 2002; Coyne et al, 2002). The number of patients that will be treated for psychiatric illnesses by primary care physicians are expected to rise even further, due factors such as the Affordable Care Act (ACA), which have made medical and mental health care more available (Barkil-Oteo, 2013).
Now more than ever before, mental health patients are being seen outside of traditional behavioral health modalities, with primary care being the greatest sector (Wang et al, 2006). Perhaps what is most alarming is that primary care physicians are more likely to treat their patients with depression than refer them out to any mental health care specialists (Gray et al, 2005; Kolbasovsky et al, 2005; Coyne et al 2002; Olfson et al, 2009). 
It appears that our current understanding and management of Depressive Disorders are fundamentally flawed. An under recognized percentage of patients presenting with depressive symptoms are in fact incorrectly diagnosed at presentation and therefore provide insufficient or misguided treatment regimen (Clark, 2011). The results of imprecise diagnosis and inappropriate treatment include suboptimal rates of remission, diminished quality of life for patients and often tragedy (Zimmerman, 2008; Basco et al, 2008; Wells et al, 2000). 
 While our arsenal of treatment modalities and pharmacotherapeutics has expanded to an adequate degree (Olfson et al, 2002), their deployment is far too frequently misdirected and our rate of successful outcomes is unacceptably low (Gelenberg et al, 2010; Gray et al, 2005).
Our empirical evidence of successful treatment remains unimpressive and inadequate, despite increasing awareness of the prevalence of depression, gradually diminishing stigma associated with the diagnosis of depression, and an expanding and seemingly adequate arsenal of psychopharmacologic and psychotherapeutic resources (Forand & DeRubeis, 2013). The primary care setting, therefore, is significant when addressing the issues and improvement needed for diagnosis and treatment of depressive disorders.

In order to examine the direction of current psychiatric care, primary care physicians should be focused on since they see the majority of depressive patients. While there is a flood of research addressing issues in the primary care setting, there lacks qualitative research with interviewing of primary care physicians to understand how they are in fact experiencing treating psychiatric patients, and if this is where we should address the issues and employ improvement needed for diagnosis and treatment of depressive disorders.
References

Barkil-Oteo, A. (2013). Collaborative care for depression in primary care: how psychiatry could "troubleshoot" current treatments and practices. Yale Journal of Biology & Medicine, 86(2):139-46.

Basco, M.R., Jacquot, C., Thomas, C. & Knack, J,M, (2008).Underdiagnosing and Overdiagnosing Psychiatric Comorbidities. Psychiatric Times, 25:8–10

Clark, D. M. (2011). Implementing NICE guidelines for the psychological treatment of depression and anxiety disorders: The IAPT experience. International Review of Psychiatry, 23(4), 318–327. doi:10.3109/09540261.2011.606803

Coyne, J.C., Thompson, R., Klinkman M.S., Nease, D.E. (2002). Emotional disorders in primary care. Journal of Consulting and Clinical Psychology, 70(3):798-809.

Frankfort-Nachmias, C., & Nachmias, D. (2008). Research methods in the social sciences (7th ed.). New York: Worth.

Forand, N.R. & DeRubeis, R.J. (2013). Pretreatment anxiety predicts patterns of change in cognitive behavioral therapy and medications for depression. Journal of Consulting and Clinical Psychology, 81(5):774-82

Gelenberg A.J., Freeman M.P., & Markowitz J.C. (2010). Practice Guideline for The Treatment of Patients With Major Depressive Disorder. The American Psychological Association. Received from http://psychiatryonline.org/data/Books/prac/PG_Depression3rdEd.pdf.

Gray, G., Brody, D.S., and Johnson,D. (2005). The Evolution of Behavioral Primary Care. Professional Psychology: Research and Practice, 36(2)123-129.

Kolbasovsky, A., Reich, L., Romano, I., and Jaramillo, B. (2005). Integrating behavioral health into primary care settings: A pilot project. Professional Psychology Research and Practice, 36(2):130-135 

Kroenke, K., Spitzer R.L., Williams J.B.W., and Lowe, B. (2010). The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. General Hospital Psychiatry, 32:345–359.

Olfson, M., Marcus, S., Druss, B., Elinson, L., Tanielian T., Pincus, H. (2002). National Trends in the Outpatient Treatment of Depression. The Journal of the American Medical Association, 287(2):203-9.

Spitzer, R.L., Williams, J.B., Kroenke, K,  Lowe, B. (2014). Test Review: Patient Health Questionnaire–9 (PHQ-9). Rehabilitation Counseling Bulletin, 57 (4) 246-248

Wang P.S., Demler O., Olfson M., Pincus H.A., Wells, K.B., Kessler, R.C. (2006). Changing profiles of service sectors used for mental health care in the United States. American Journal of Psychiatry,163:1187–1198.

Wells, KB., Sherbourne,C. Schoenbaum, M., Duan, N., Meredith, L., Unützer, J., Miranda, J., Carney M.F., & Rubenstein, L.V. (2000).Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. The Journal of the American Medical Association, 283(24):3204.

Zimmerman, M. (2008). Is diagnosis of comorbidities obsolete? Psychiatric Times, 25:1, 6–7

 


Author Information and Blog Introduction

My experience as a PhD student and clinical psychologist in training has evolved to be quite different than I imagined. Practitioners treating mental illness join the field for various reasons; career opportunities, exposure and experiences, personal qualities, etc. Growing up in a family of psychologists, I somewhat inherited the role and aspired to become a psychotherapist at a young age. However, as I began getting deeper into my work experiences, I found that my ambitions grew further than just becoming a “talk doctor.” My first true role in the field was working with active duty military families whom had children with severe medical and mental health disabilities. For 6 years I worked one on one with families in their homes, traveled with them to doctor appointments and procedures, developed unique skills, and reflected on not only my work but also the healthcare system. I spent more hours with these families in one month than a psychologist would spend face-to-face with a patient over the course of a year.
I began to recognize a pattern throughout the families I worked with: ineffective psychiatric medication treatment as well as, what appeared to be, patients trapped on a healthcare merry-go-round. The lack of proper treatment and its impact on individuals were not exposed to me in my early studies, but rather became an interest of mine through experience. I later worked with and studied alternative medicine for psychiatric care, and while this route can be effective, it does not appear to “cure” moderate to severe mental health illnesses on its own. I began to wonder as to the existence of comprehensive treatment of patients with severe mental illness, specifically Major Depressive Disorder. Why has the development of newer psychotropic medications not had an impressive impact on treatment?
Around the time I began the PhD clinical psychology program, I started networking with professionals in my city to get a better understanding of this phenomenon. I eventually met and worked with family physicians who had a different approach to treating mood disorders and Major Depressive Disorder; they extensively self-educated themselves of psychotropic medications, neuroscience, diagnosing, and spent more time with each patient: on average 60 minutes. I began to wonder, what factors can improve patient outcomes of Major Depressive Disorder?

As an emerging professional psychologist, I believe these questions should be addressed and this social change topic should evolve in a social change movement. Furthermore, this topic should face extra attention as mental health professionals and physicians began to further collaborate in an integrative model.